Cellectar Biosciences, Inc. SEC filings CLRB
Cellectar Biosciences, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 7, 2011. Its latest annual report, Form 10-K, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 13, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 4, 2026 | — |
| 4/A | Ownership document | Jul 10, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 10, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 8, 2026 |
| 3 | Initial insider ownership | Jun 9, 2026 | May 18, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 5, 2026 | — |
| 424B3 | Prospectus | Jun 2, 2026 | — |
| EFFECT | Filing | Jun 1, 2026 | — |
| CORRESP | Letter to the SEC | May 29, 2026 | — |
| S-1/A | Amended registration statement | May 29, 2026 | — |
| DEFA14A | Additional proxy material | May 28, 2026 | — |
| DEF 14A | Proxy statement | May 28, 2026 | Jul 7, 2026 |
| UPLOAD | Letter from the SEC | May 22, 2026 | — |
| S-1 | Registration statement | May 19, 2026 | — |
| PRE 14A | Preliminary proxy statement | May 18, 2026 | May 18, 2026 |
| 8-K |
Current report
Officer or director change
|
May 18, 2026 | May 17, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 11, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 8, 2026 | May 4, 2026 |
| 424B5 | Prospectus supplement | May 6, 2026 | — |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2026 | Mar 4, 2026 |
| 10-K | Annual report | Mar 4, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 4, 2026 | — |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 424B3 | Prospectus | Nov 21, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| S-1 | Registration statement | Oct 20, 2025 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Change to shareholder rights, Other events
|
Oct 10, 2025 | Oct 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 6, 2025 | Oct 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 8, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 8, 2025 | — |
| 4 | Insider transaction | Jul 3, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 2, 2025 |
| 424B4 | Prospectus | Jul 2, 2025 | — |
| EFFECT | Filing | Jul 1, 2025 | — |
| CORRESP | Letter to the SEC | Jun 30, 2025 | — |
| CORRESP | Letter to the SEC | Jun 30, 2025 | — |
| S-1/A | Amended registration statement | Jun 30, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| S-1 | Registration statement | Jun 26, 2025 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jun 25, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Other events
|
Jun 18, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 13, 2025 |
| DEFA14A | Additional proxy material | Jun 11, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Regulation FD disclosure
|
Jun 5, 2025 | Jun 5, 2025 |
| UPLOAD | Letter from the SEC | May 29, 2025 | — |
| DRS | Filing | May 23, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
May 1, 2025 | Apr 30, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 13, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Apr 18, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Mar 17, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 12, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| 424B3 | Prospectus | Feb 7, 2025 | — |
| EFFECT | Filing | Feb 6, 2025 | — |
| CORRESP | Letter to the SEC | Feb 4, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 3, 2025 | — |
| 8-K |
Current report
Listing notice
|
Jan 31, 2025 | Jan 30, 2025 |
| S-1 | Registration statement | Jan 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 27, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2025 | Jan 12, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure, Other events
|
Dec 11, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 18, 2024 | Nov 18, 2024 |
| 10-Q | Quarterly report | Nov 18, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Nov 15, 2024 | Nov 15, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| NT 10-Q | Filing | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Nov 1, 2024 | Nov 1, 2024 |
| 10-Q | Quarterly report | Oct 29, 2024 | Jun 30, 2024 |
| 10-Q/A | Amended quarterly report | Oct 29, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | Oct 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 23, 2024 | Aug 20, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 14, 2024 | — |
| NT 10-Q | Filing | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Restatement
|
Aug 9, 2024 | Aug 9, 2024 |
| EFFECT | Filing | Jul 23, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jul 23, 2024 | Jul 23, 2024 |
| CORRESP | Letter to the SEC | Jul 22, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Regulation FD disclosure
|
Jul 22, 2024 | Jul 21, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 11, 2024 | — |
| 8-K |
Current report
Auditor change
|
Jul 11, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 25, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 14, 2024 | Jun 14, 2024 |
| UPLOAD | Letter from the SEC | May 31, 2024 | — |
| S-3 | Shelf registration | May 24, 2024 | — |
| DEFR14A | Filing | May 16, 2024 | — |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 25, 2024 | — |
| 10-K/A | Amended annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2024 | Mar 27, 2024 |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 2, 2024 | Feb 2, 2024 |
| SC 13G | Ownership over 5% (passive) | Jan 31, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 25, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Other events
|
Jan 9, 2024 | Jan 8, 2024 |
| 4 | Insider transaction | Dec 12, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Dec 12, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Dec 12, 2023 | Dec 8, 2023 |
| 4 | Insider transaction | Dec 12, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Dec 12, 2023 | Jun 23, 2023 |
| SC 13G | Ownership over 5% (passive) | Dec 7, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Dec 5, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 29, 2023 | Nov 21, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 424B3 | Prospectus | Oct 31, 2023 | — |
| EFFECT | Filing | Oct 30, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
|
Oct 27, 2023 | Oct 25, 2023 |
| CORRESP | Letter to the SEC | Oct 26, 2023 | — |
| S-3/A | Form s-3/a | Oct 25, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 12, 2023 | — |
| S-3 | Shelf registration | Oct 5, 2023 | — |
| DEF 14A | Proxy statement | Oct 2, 2023 | Oct 25, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 22, 2023 | Oct 25, 2023 |
| D | Filing | Sep 22, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Sep 8, 2023 | Sep 5, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 21, 2023 | Aug 16, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Other events
|
Jun 29, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 29, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Jun 28, 2023 | Jun 28, 2023 |
| 4 | Insider transaction | Jun 28, 2023 | Jun 28, 2023 |
| 4 | Insider transaction | Jun 28, 2023 | Jun 28, 2023 |
| 4 | Insider transaction | Jun 28, 2023 | Jun 28, 2023 |
| 4 | Insider transaction | Jun 28, 2023 | Jun 28, 2023 |
| DEFA14A | Additional proxy material | Jun 20, 2023 | — |
| 8-K/A |
Amended current report
Other events
|
Jun 20, 2023 | Jun 14, 2023 |
| DEFA14A | Additional proxy material | Jun 14, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 14, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 13, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLRB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Florham Park, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1279704
- Former names
- NOVELOS THERAPEUTICS, INC. (until Feb 11, 2014); COMMON HORIZONS INC (until Jun 2, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.